These initial findings have paved the way to expand the program into a more comprehensive
pediatric precision oncology program that researchers expect to launch in 2016, which will include offering sequencing to pediatric cancer patients diagnosed at other hospitals.
Our groundbreaking
Pediatric Mi - Oncoseq Program is an internationally known
precision oncology program focusing on the genetic analysis of
pediatric cancer patients including in children with malignant brain tumors, and determines whether targeted treatments may be available based upon their personalized tumor genomic sequencing profiles.